Brought to you by:
-
Grasping the nettle: The need to tackle PAD problem head on is huge, says 2024 Veith lecturer
Huge opportunities abound for vascular surgeons to take a leadership role on the frontlines of a developing peripheral arterial disease (PAD) treatment crisis in the U.S., says Michael Conte, MD, who gave the second annual Frank J. Veith Distinguished Lecture at VAM 2024. Conte, speaking on “The State of PAD Care in the U.S.,” called…
-
A calling seeded in childhood: Uniting vascular surgery for the betterment of patient care
Many attending the 2024 Vascular Annual Meeting (VAM; June 19–22) might have been unaware of the early life of 2023–24 Society for Vascular Surgery (SVS) President Joseph Mills, MD. Amongst an intrepid childhood following his father’s career as a dentist, incoming SVS President Matthew Eagleton, MD, noted as he introduced Mills to give the 2024…
-
adherence, asymptomatic carotid stenosis, best medical therapy, Carotid disease, Carotid stenosis, JVS, medication, smoking cessation, SVS guidelines, VAM 2024
Smoking cessation remains a ‘ripe target’ for improved medication adherence in carotid disease
New data presented at the 2024 Vascular Annual Meeting (VAM) held June 19–22 in Chicago have revealed poor overall rates of medical therapy adherence in moderate asymptomatic carotid stenosis patients—with smoking cessation representing a “ripe target” for improvement moving forward. “The objectives of this study were to examine adherence to three common tenets of medical…
-
Incentives and coaching offer promise for improving supervised exercise therapy completion in claudicants
Study findings were presented during Saturday, June 22’s Plenary Session 7 support current vascular guidelines advocating for effective supervised exercise therapy (SET) prior to offering vascular intervention for patients with intermittent claudication. That is the belief of Colin Cleary, PhD, a fourth-year medical student at the University of Connecticut School of Medicine in Farmington, and…
-
VAM 2024: Paper exploring stroke rates in arch TEVAR emerges as winner of Poster Competition
The 2024 Vascular Annual Meeting (VAM) in Chicago showcased emerging talent in vascular surgery through a moderated Poster Competition held over two days of the conference. This event provided a platform for research and recognized excellence among the next generation of vascular surgeons. Hassan Chamseddine, MD, a research fellow from Henry Ford Hospital in Detroit,…
-
Endovascular CFA treatment associated with increased rate of long-term CFA-specific reintervention, study finds
A recent study suggests that endovascular treatment of the common femoral artery (CFA) is associated with an increased rate of long-term CFA-specific reintervention, regardless of indication. Nicholas Wells, a medical student at Yale School of Medicine in New Haven, USA, presented this and other key findings from a tertiary care centre analysis of open and endovascular…
-
New data on TAMBE outcomes in complex aortic aneurysms revealed
The US Food and Drug Administration (FDA)-approved Gore Excluder Thoracoabdominal Branch Endoprosthesis (TAMBE) has been shown to be safe and effective at 30 days for the treatment of patients with complex aortic aneurysms involving the visceral aorta. This is according to findings of the TAMBE trial, a prospective non-randomised multicentre study investigating the use of the…
-
Patient selection may explain ‘counterintuitive’ relationship between carotid stenting volume and outcomes in new study
High stroke and death rates relating to carotid stenting in the Pacific Northwest may be driven by the selection of high-risk patients with less than 80% stenosis, and reducing the frequency of stenting in this high-risk group—along with better adherence to guideline-recommended medical management—could improve regional outcomes. This was among the key concluding messages delivered…
-
TCAR and endarterectomy both ‘reasonable’ but stenting linked to worse outcomes in kidney disease patients
A study examining outcomes between different carotid revascularisation procedures has concluded that transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable choice” in severe chronic kidney disease (CKD) and haemodialysis patients—but transfemoral carotid artery stenting (TF-CAS) appears more likely to result in worse outcomes. “And, additionally, the majority of these patients are surviving long enough to…
-
Linda Harris elected SVS vice president
The Society for Vascular Surgery (SVS) has announced Linda Harris, MD, as its next vice president, meaning that she enters the presidential line and will become SVS leader in 2026. The announcement was made during the SVS Annual Business Meeting, held on June 22 in Chicago as part of the 2024 Vascular Annual Meeting (VAM…